In the last few years, the molecular and genetic nature of the granulocyte colony-stimulating factor, which controls proliferation and differentiation of neutrophils, has been characterized. Recent clinical application of G-CSF proves that this hormone is effective in the treatment of patients suffering from neutropenia.
No takes yet. Share an insight, caveat, or question.
Shigekazu Nagata (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from BioEssays